I won’t stop asking the questions until I get some answers.
Bureaucrat: I would also indicate that there are a number of conversations that we have answered a number of times through questions on notice
Yours truly: And I haven’t got the answers. That’s why I’m still here asking the same questions.
Another day, another deflection.
Community Affairs Legislation Committee
15/02/2024
Estimates
HEALTH AND AGED CARE PORTFOLIO
Office of the Gene Technology Regulator
Senator RENNICK: It’s clear in your product assessment report that you used transfection. This is the first drug that’s ever been designed with a positive lipid that’s normally toxic to the human body to cross a cell membrane. Do you agree with that—that this is the first drug that’s ever used the process of transfection? Do you understand that and the implications that brings?
Prof. Lawler: I understand the mechanism that is used by this vaccine, and I also understand the comments that have been made previously regarding the lipids—the lipid nanoparticles—that are utilised. I also understand that they’ve been asked and answered a number of times as well in Senate questions.
Senator RENNICK: What does the transfection do? Explain to me what that does.
Prof. Lawler: I’m going to seek to ask Dr Robertson to join us at the table to discuss this with you. I would also indicate, as I’ve already mentioned, that there are a number of conversations that we have answered a number of times through questions on notice.
Senator RENNICK: I haven’t got the answers. That’s the problem. That’s why I’m still here, asking the same questions.
